References
Zhang Y, Proenca R, Maffei M, et al.: Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425–432.
Farooqi IS, Jebb SA, Langmack G, et al.: Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999, 341:879–884.
Farooqi IS, Matarese G, Lord GM, et al.: Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002, 110:1093–1103.
Chan JL, Mantzoros CS: Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa. Lancet 2005, 366:74–85.
Harris RB, Zhou J, Redmann SM Jr, et al.: A leptin dose-response study in obese (ob/ob) and lean (+/?) mice. Endocrinology 1998, 139:8–19.
Javor ED, Cochran EK, Musso C, et al.: Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. Diabetes 2005, 54:1994–2002.
Lee JH, Chan JL, Sourlas E, et al.: Recombinant methionyl human therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy (HAART). J Clin Endocrinol Metab 2006, 91:2605–2611.
Fruebis J, Tsao TS, Javorschi S, et al.: Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 2001, 98:2005–2010.
Berg AH, Combs TP, Du X, et al.: The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001, 7:947–953.
Maeda N, Shimomura I, Kishida K, et al.: Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002, 8:731–737.
Fain JN, Madan AK, Hiler ML, et al.: Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004, 145:2273–2282.
Yang WS, Lee WJ, Funahashi T, et al.: Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001, 86:3815–3819.
Kelesidis I, Kelesidis T, Mantzoros CS: Adiponectin and cancer: a systematic review. Br J Cancer 2006, 94:1221–1225.
Yamauchi T, Kamon J, Minokoshi Y, et al.: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002, 8:1288–1295.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brennan, A.M., Mantzoros, C.S. Leptin and adiponectin: Their role in diabetes. Curr Diab Rep 7, 1–2 (2007). https://doi.org/10.1007/s11892-007-0001-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11892-007-0001-y